<DOC>
	<DOCNO>NCT00064766</DOCNO>
	<brief_summary>Irregular prolong menstrual bleeding and/or spot common side effect patient use progestin-only hormonal contraception levonorgestrel implant ( Norplant ) . Doxycycline , drug approve Food Drug Administration ( FDA ) treat gum disease , may reduce occurrence uterine bleed spot woman use Norplant . This study evaluate effect doxycycline uterine bleeding/spotting woman use Norplant .</brief_summary>
	<brief_title>Norplant Irregular Bleeding/Spotting</brief_title>
	<detailed_description>A high percentage woman use progestin-only contraception experience breakthrough bleeding ( BTB ) spot cause impaired lifestyle result decrease compliance contraceptive method . There need effective , low-cost , easily adapt treatment reduce bleed spot progestin-only contraceptive . The molecular environment endometrium woman BTB spot contains abnormally high level pro-inflammatory cytokine ( TNF-alpha IL-1 beta ) abnormally high level protease ( matrix metalloproteinases [ MMPs ] neutrophil elastase ) , prevent normal tissue repair . Doxycycline ( DOX ) inexpensive , FDA approve antibiotic inhibits MMPs reduce nitric oxide synthesis . This study evaluate DOX treatment progestin-only contraceptive induced BTB spotting , characterize endometrial molecular biologic change occur DOX treat patient , determine effect Norplant sexual function testosterone level . All participant study receive Norplant . Participants randomize receive either DOX ( 20 mg twice day ) placebo 6 month . Participants 9 study visit 24 week study . Study visit include medical history , physical exam , blood urine test . Participants also three periodontal evaluation three endometrial biopsy . At end study , participant may choose Norplant implant remove wish discontinue Norplant use ; otherwise implant may remain 5 year .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Inclusion Criteria Regular menstrual period last 2 cycle Currently use hormonal contraceptive , include oral contraceptive , patch , ring , Norplant 2 month prior study entry , DepoProvera 12 month prior study entry Currently use tetracyclineclass antibiotic Normal Pap smear Exclusion criterion Pregnancy breastfeed within 2 month study entry Chronic migraine headache Uncontrolled high blood pressure Untreated sexually transmit disease Alcoholism drug abuse within 12 month study entry Insulin dependent diabetes Liver , kidney , gallbladder disease Participation another clinical trial within 30 day study entry History cancer History blood clot , stroke , heart disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2003</verification_date>
	<keyword>Norplant</keyword>
	<keyword>Periodontal disease</keyword>
	<keyword>Endometrial bleeding</keyword>
	<keyword>Progestin-induced endometrial bleeding</keyword>
</DOC>